Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today announced that the first commercial case has ...

Direct viral infection of solid tumors can cause tumor cell death, but these techniques offer the opportunity to express exogenous factors to enhance the antitumor response. We investigated the ...

Chronic pain affects 30 percent of people in America, according to the New England Journal of Medicine. That’s just one reason for the explosion in opioid abuse and addiction. Now there’s a new ...

A new medical device promises to remove pain without prescription painkillers.A local pilot is among the first to get the implant. Mike Boinski is extremely active - flying, scuba diving, biking - but ...

A unique and spontaneously mutated and naturally mutated HSV 1, HF10, has been demonstrated to be an effective oncolytic agent in preclinical contexts including peritoneal dissemination models, breast ...